Dr Reddys Laboratories RDY
NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) EBT (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) recorded EBT of $58.37 million in the quarter ended Jun 30, 2026, down 73.8% from $222.56 million a year earlier but up 168.0% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) EBT (2009 - 2026) Analysis & Trends

On a TTM basis, Dr Reddys Laboratories' EBT came in at $463.79 million as of Jun 30, 2026, down 48.8% year-over-year; for the year ended Mar 31, 2026, it came in at $584 million, down 35.7% from the prior year.

  • Annual EBT has a five-year compound annual growth rate of 10.1% (years ended Mar 2021 to Mar 2026).
  • Across earlier years, EBT came in at $908.6 million in the year ended Mar 31, 2025 (+5.4%), $862 million in the year ended Mar 31, 2024 (+17.4%), $734 million in the year ended Mar 31, 2023 (+72.3%) and $426 million in the year ended Mar 31, 2022 (+18.0%).
  • Quarterly EBT has ranged from $21.78 million in the quarter ended Mar 31, 2026 to $231.58 million in the quarter ended Mar 31, 2025 over the past five years.
  • On a year-over-year basis, EBT has declined for five consecutive quarters, with an average decline of 21.9% over the last eight quarters.
  • Peak year-over-year performance for EBT in the last five years was growth of 572.3% in the quarter ended Mar 31, 2023, against a decline of 90.6% in the quarter ended Mar 31, 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $21.78 million (quarter ended Mar 31, 2026), $173.26 million (quarter ended Dec 31, 2025) and $210.38 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 6.75 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 4.28 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.27 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 2.80 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.77 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -10.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -653.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.39 Bn
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn 58.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 58.37 Mn
Mar 31, 2026 21.78 Mn
Dec 31, 2025 173.26 Mn
Sep 30, 2025 210.38 Mn
Jun 30, 2025 222.56 Mn
Mar 31, 2025 231.58 Mn
Dec 31, 2024 221.97 Mn
Sep 30, 2024 228.84 Mn
Jun 30, 2024 225.62 Mn
Mar 31, 2024 192.86 Mn
Dec 31, 2023 219.26 Mn
Sep 30, 2023 231.46 Mn
Jun 30, 2023 230.00 Mn
Mar 31, 2023 222.00 Mn
Dec 31, 2022 162.00 Mn
Sep 30, 2022 199.00 Mn
Jun 30, 2022 190.05 Mn
Mar 31, 2022 33.02 Mn
Dec 31, 2021 81.00 Mn
Sep 30, 2021 128.00 Mn
API Access

Dr Reddys Laboratories EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=RDY&period=max&api_key=YOUR_API_KEY